AXIM Biotechnologies's total assets for Q2 2026 were $3.29M, a decrease of -2.47% from the previous quarter. AXIM total liabilities were $14.50M for the fiscal quarter, a 0.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.